SavedAdd your journal

Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2006 / Cilt: 16 - Sayı: 2

Linezolid susceptility in Staphylococcus strains

Stafilokoklarda linezolid duyarlılığı

Neval AĞUŞ
Nisel ÖZKALAY
Abdullah CENGİZ
Nuriye VATANSEVER
Pages
87–89
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Linezolid antibiotic can be used as reliable alternative antibiotics for the treatment of infections caused by serious staphylococcal strains.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Staphylococcus is an important causative agent in various infections.
📊
Key Findings & Data:Methods: 168 S. aureus strains and 95 coagulase negative staphylococcus strains which isolated from various clinical specimens were investigated meticiline resistance and linezolid susceptibility.
💡
Conclusion & Impact:Conclusion: Linezolid antibiotic can be used as reliable alternative antibiotics for the treatment of infections caused by serious staphylococcal strains.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Mikrobiyal duyarlılık testleri · Metisilin direnci · Staphylococcus

Abstract

Aim: Staphylococcus is an important causative agent in various infections. The meticillin resistance and antibiotic susceptibility tests should be taken into account for initiating emprical therapy of the infections when staphylococci are suspected. The aim our study is to investigate the meticillin resistance ratio and linezolid susceptibilty for staphylococcus strains in our hospital. Methods: 168 S. aureus strains and 95 coagulase negative staphylococcus strains which isolated from various clinical specimens were investigated meticiline resistance and linezolid susceptibility. Results: Meticillin resistance were found 75.5% for S. aureus and 69.4% for coagulase negative staphylococcus. None of the strains were found to be resistant to linezolid. Conclusion: Linezolid antibiotic can be used as reliable alternative antibiotics for the treatment of infections caused by serious staphylococcal strains.

Özet

Amaç: Stafilokoklar çeşitli infeksiyonlarda önemli bir etken olarak karşımıza çıkmaktadır. Stafilokok düşünülen infeksiyonlarda empir'ık tedavi başlamak için metisi/in resistansı ve antibiyotik duyarlılıkların bilinmesi gereklidir. Çalışmamızda hastanemizdeki stafilokoklarda metisilin direnç oranı ve linezolid duyarlığı araştırılmıştır. Yöntem: Çeşitli klinik örneklerden üretilen 168 S. aureus ve 95 koagulaz negatif stafilokok'da metisilin direnci ve linezolid duyarlılığı araştırılmıştır. Bulgular: Hastanemizdeki stafilokoklardaki metisilin direnci S. aureus için %75.5, koagulaz negatif stafilokok için %69.4 olarak tespit edilmiştir. Stafilokok suşlarının hepsi linezolide duyarlı bulunmuştur. Sonuç: Ciddi stafilokok infeksiyonların tedavisinde linezolidin iyi bir alternatif olduğu düşünülmüştür

🔖

Cite This Article

AĞUŞ, N., ÖZKALAY, N., CENGİZ, A., VATANSEVER, N. (2006). Linezolid susceptility in Staphylococcus strains. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 16 - Sayı: 2, 87–89. https://ajindex.com/articles/268564

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Poly MC, Gre'laud C, Martin C, De Lumley L, Denis F. First clinical isolate of vancomycin intermediate Staphylococcus aureus in a French hospital. Lancet 1998;351:1212. 2.Hiromatsu K, Honaki H. Meticillin resistant S. aureus clinical strain with reduced Vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-6. 3.Wilcox MB. Update on Linezolid: The first Oxazolidone Antibiotic. Expert Opin Pharmacother 2005;6: 2315-26. 4.Clinical and Laboratory Standards institute Perfor¬ mance Standards for Antimicrobial Susceptibility Testing, 15th Informational supp, Document M2-A8, CLSI, Villanova, 2005. 5.Ünlü Güngör V, Ünlü M, Bakıcı MZ, Gür D. Kan kültürlerinden soyutlanan Staphylococcus köken¬ lerinin antibiyotik duyarlılıklanhın biomic sistemi ile saptanması. İnfek Derg 2001; 15:235-8. 6.Howe RA, Bowker KE, Walsh TR, Feest TG, Mac Gowan AP. Vancomycin resistant Staphylococcus aureus. Lancet 1998;351:602. 7.Samra Z, Öf er O, Shumuely H. Susceptibility of methicillin-resistant Staphylococcus aureus to vanco- mycine, teicoplanin, linezolid, psitinamycen and other antibiotics. Isr Med Assoc J 2005;7:14-50. 8.Gülay Z, Atay T, Yuluğ N. Staphylococcus aureus suşlarında Vankomisin direncinin araştırılması. ANKEM Derg 1998;12:101. 9.Tünger A, Aydemir S, Uluer S, Çilli F. Invitro activity of linezolid & quinupristin/dalfopristin agains Gram positive cocci. Indian J Med Res 2004;120:546-52. 10.Simonsen GS, Bergh K, Bevanger L, Digranes A, Gausted D, Melby KK, Hoiby EA. Susceptibility to quinupristin-dalfopristin and linezolid in 839 clinical isolates of Gram positive cocci from Norway. Scand J Infect Dis 2004-36:254-8. 11.Viudes A, Perez Belles C, Tallon P, Cano J, Peman J, et al. Susceptibility of Staphylococcus aureus isolated from blood to 11 antimicrobial agents and a review of the literature. Rev Esp Quimioter 2002; 15:158-68. 12.Abb J. Invitro activity of linezolid, quinupristin-dalfop¬ ristin, vancomycin, teicoplanin, moxifloxacin and mupi- rocin against methicillin- resistant Staphylococcus aureus comparative evaluation by the E test and a broth microdilution method. Diagn Microbial Infect Dis 2002; 43:319-21.